350 Drugs Getting Pricier in 2026 | Simplefill
At least 350 brand‑name medications are expected to see U.S. price hikes in 2026, including vaccines and blockbuster drugs for cancer, COVID‑19, and chronic conditions. For patients and families nationwide, those increases will pile onto already rising premiums and out‑of‑pocket costs, making access to a full‑service prescription assistance program more important than ever.
Why Are 350 Drugs Getting More Expensive in 2026?
Drugmakers plan to raise list prices on more than 350 branded medications starting in 2026, up from roughly 250 drugs that saw increases the year before. The median hike is around 4%, which sounds modest but becomes painful when applied to already expensive specialty medications people rely on every month.
Several forces are driving this:
- Manufacturers spreading smaller increases across more drugs instead of taking double‑digit hikes on a few products, partly in response to political and public pressure.
- Companies moving prices ahead of new Medicare penalties for hikes that outpace inflation and the rollout of Medicare’s price negotiation program.
- An overall spike in health costs, with prescription drugs accounting for nearly a quarter of spending and projected to be a key reason health spending will grow in 2026.
Because list prices are the starting point for deductibles, coinsurance, and premiums, these hikes hit insured and uninsured people across the U.S., regardless of where they live.
Which Types of Medications Are Most Affected?
The 350‑drug list covers a wide range of therapies, but several high‑impact categories stand out.
- Cancer treatments: Blockbuster oncology drugs like Ibrance are on the list, and even a modest increase can mean thousands more per year for people in active treatment.
- Vaccines: COVID‑19 vaccines such as Comirnaty and other immunizations for RSV and shingles face price hikes, affecting adults needing boosters or catch‑up doses.
- COVID antivirals: Treatments like Paxlovid are included, impacting high‑risk patients who need early access to reduce hospitalization risk.
- Chronic disease drugs: Diabetes, heart, and respiratory medications are also seeing adjustments, often for patients who are already juggling multiple prescriptions.
When you combine these changes with higher premiums and cost‑sharing, it’s clear why more patients are turning to a patient assistance program or medication assistance program to keep their treatment plans on track.
Which Specific Drugs Should Patients Watch in 2026?
The table below highlights representative brand‑name drugs that are either directly cited in 2026 price‑hike reporting or are typical of the high‑cost therapies patients struggle with. Each name links to a dedicated Simplefill patient assistance program page.
| Drug | Primary Use | Why 2026 Price Changes Matter |
|---|---|---|
| Ibrance | Breast cancer | A widely used cancer therapy; mid‑single‑digit increases add thousands per year for long‑term treatment. |
| Paxlovid | COVID‑19 antiviral | Higher list prices raise costs for high‑risk patients, especially as public‑health coverage wanes. |
| Comirnaty | COVID‑19 vaccine | Facing a reported 15% increase, affecting out‑of‑pocket costs for boosters. |
| Januvia | Type 2 diabetes | Represents high‑spend diabetes drugs; price changes ripple through deductibles and coinsurance. |
| Entresto | Chronic heart failure | Long‑term therapy; price hikes strain retirees and people on fixed incomes. |
| Dupixent | Asthma, eczema | High‑cost biologic; even small % increases create big dollar jumps for families. |
| Ozempic | Type 2 diabetes | High demand and varying coverage; list‑price increases hit both insured and uninsured. |
How Do These Price Hikes Fit Into 2026 Health‑Cost Trends?
The 350‑drug story is part of a broader spike in U.S. health spending. Employers expect costs to jump about 9%, driven by specialty medications and rising hospital costs. Our blog on how much health spending will grow in 2026 explains these trends in detail.
What Can Patients Do If Their Drug Is on the 350‑Drug List?
- Review your plan’s 2026 formulary to see if your drug is moving to a higher cost‑sharing tier.
- Ask your prescriber about lower‑cost generic or biosimilar alternatives.
- Look up the patient assistance program for your specific drug to see if you qualify for help.
- Enroll in a full‑service medication assistance program that handles the applications and renewals for you.
Get Affordable Access to Prescription Medications
Simplefill is a full-service prescription assistance company that maintains patients’ enrollment in all sources of assistance available to them.
Apply today by calling 877-386-0206. A representative will contact you within 24 hours.
FAQs About 350 Drugs Getting Pricier in 2026
Why are drugmakers raising prices on so many medications at once?
Manufacturers are applying modest increases—around 4%—across more drugs instead of massive hikes on just a few, navigating new Medicare penalties for price growth above inflation.
Will insurance or Medicare protect me from all of these price hikes?
Insurance softens the blow, but higher list prices still feed into deductibles, coinsurance, and future premiums, especially for high‑tier specialty medications.
Can a prescription assistance program really help with high‑cost brand‑name drugs?
Yes, full‑service programs can often reduce or eliminate out‑of‑pocket costs for eligible patients by enrolling them in manufacturer or nonprofit assistance for drugs like Ibrance, Ozempic, or Dupixent.
blog